Year archive

Entheon Biomedical Corp. — 2025 filings

All 25 regulatory filings released by Entheon Biomedical Corp. (ENBI) in 2025, sourced directly from the official regulator.

25 Filings

2025 Period

2025 filings (25)

Filing	Released	Lang
Other.pdf Regulatory Filings	2025-11-25	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-11-25	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-11-25	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-11-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-07-19	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-07-19	English
Interim MD&A - English.pdf Management Reports	2025-07-19	English
Other.pdf Interim / Quarterly Report Q2 2025	2025-07-19	English
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2025-04-16	English
News release - English.pdf Board/Management Information	2025-04-07	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q4 2025	2025-04-01	English
Interim MD&A - English.pdf Management Reports	2025-04-01	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-04-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-04-01	English
News release - English.pdf Share Issue/Capital Change	2025-04-01	English
Material change report - English.pdf M&A Activity	2025-03-17	English
News release - English.pdf M&A Activity	2025-03-14	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-03-05	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-03-05	English
Annual MD&A - English.pdf Management Reports	2025-03-05	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-05	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-05	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-03-05	English
Material change report - English.pdf Capital/Financing Update	2025-01-30	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-01-09	English